|
ARL17A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.42869999999007E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.075100E-03 |
| Normal-vs-Stage2 |
2.909700E-02 |
| Normal-vs-Stage3 |
2.04799999999894E-05 |
| Normal-vs-Stage4 |
1.52720000001771E-06 |
| Stage1-vs-Stage2 |
9.787400E-01 |
| Stage1-vs-Stage3 |
1.917530E-02 |
| Stage1-vs-Stage4 |
1.177000E-03 |
| Stage2-vs-Stage3 |
1.247780E-01 |
| Stage2-vs-Stage4 |
3.673800E-02 |
| Stage3-vs-Stage4 |
4.381000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.244400E-04 |
| Normal-vs-AfricanAmerican |
8.35390000508696E-08 |
| Normal-vs-Asian |
3.724200E-01 |
| Caucasian-vs-AfricanAmerican |
1.395730E-04 |
| Caucasian-vs-Asian |
7.530600E-01 |
| AfricanAmerican-vs-Asian |
2.295600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.15770000000504E-06 |
| Normal-vs-Female |
5.781700E-03 |
| Male-vs-Female |
1.850090E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.236200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.824840E-04 |
| Normal-vs-Age(61-80Yrs) |
8.24970000000702E-05 |
| Normal-vs-Age(81-100Yrs) |
6.144200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.914400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.931800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.223000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.950600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.987400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.946400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.720400E-01 |
| Normal-vs-Grade 2 |
4.940200E-03 |
| Normal-vs-Grade 3 |
1.87761000000064E-05 |
| Normal-vs-Grade 4 |
4.34640000002151E-06 |
| Grade 1-vs-Grade 2 |
3.465000E-01 |
| Grade 1-vs-Grade 3 |
8.189600E-02 |
| Grade 1-vs-Grade 4 |
1.791830E-02 |
| Grade 2-vs-Grade 3 |
4.914500E-02 |
| Grade 2-vs-Grade 4 |
7.035200E-03 |
| Grade 3-vs-Grade 4 |
1.698790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.771600E-02 |
| Normal-vs-ccB subtype |
1.194010E-04 |
| ccA subtype-vs-ccB subtype |
3.743500E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.561110E-03 |
| Normal-vs-N1 |
3.003800E-04 |
| N0-vs-N1 |
1.240410E-01 |
|
|
